Abbott India announces the resignation of Mr. Ambati Venu as Director, effective December 31, 2025, due to external career opportunities. Simultaneously, the company has appointed Mr. Vivek Mohan as an Additional (Non-Executive) Director, starting January 1, 2026. Shareholders will vote on Mr. Mohan’s directorship via postal ballot.
Director Resignation
Mr. Ambati Venu has resigned from his position as Director of Abbott India, effective at the close of business hours on December 31, 2025. The resignation is due to Mr. Venu’s decision to pursue external career opportunities.
New Director Appointment
Mr. Vivek Mohan has been appointed as an Additional (Non-Executive) Director, effective January 1, 2026. The appointment follows a recommendation from the Nomination and Remuneration Committee and was approved by the Board of Directors on December 24, 2025.
Shareholder Approval
The company will seek shareholder approval for the appointment of Mr. Vivek Mohan as Director through a postal ballot. Details regarding the postal ballot will be communicated to shareholders in due course.
Vivek Mohan’s Background
Mr. Vivek Mohan will also hold the position of Abbott’s Vice President, Established Pharmaceuticals, India, starting January 1, 2026. Previously, he served as Abbott’s Divisional Vice President, Corporate Global Marketing. Mr. Mohan joined Abbott in 1992 and has held roles across the US, UK, India, Indonesia, and the Middle East.
He earned a Bachelor of Science in Microbiology from the University of Michigan in 1992 and an M.B.A. in International Business and Marketing from the University of Illinois in 1996.
Source: BSE
